000 | 01818 a2200481 4500 | ||
---|---|---|---|
005 | 20250514184701.0 | ||
264 | 0 | _c20040916 | |
008 | 200409s 0 0 eng d | ||
022 | _a0969-8051 | ||
024 | 7 |
_a10.1016/j.nucmedbio.2003.11.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHenriksen, Gjermund | |
245 | 0 | 0 |
_aSterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides. _h[electronic resource] |
260 |
_bNuclear medicine and biology _cMay 2004 |
||
300 |
_a441-9 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aActinium _xadministration & dosage |
650 | 0 | 4 |
_aAlpha Particles _xtherapeutic use |
650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCoated Materials, Biocompatible _xchemical synthesis |
650 | 0 | 4 |
_aDrug Carriers _xchemical synthesis |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFolate Receptors, GPI-Anchored |
650 | 0 | 4 |
_aFolic Acid _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _ximmunology |
650 | 0 | 4 |
_aLiposomes _xchemical synthesis |
650 | 0 | 4 | _aMetabolic Clearance Rate |
650 | 0 | 4 |
_aOvarian Neoplasms _xmetabolism |
650 | 0 | 4 |
_aRadioimmunotherapy _xmethods |
650 | 0 | 4 |
_aRadiopharmaceuticals _xadministration & dosage |
650 | 0 | 4 |
_aRadium _xadministration & dosage |
650 | 0 | 4 |
_aReceptors, Cell Surface _xmetabolism |
650 | 0 | 4 | _aStereoisomerism |
700 | 1 | _aSchoultz, B W | |
700 | 1 | _aMichaelsen, T E | |
700 | 1 | _aBruland, Ø S | |
700 | 1 | _aLarsen, R H | |
773 | 0 |
_tNuclear medicine and biology _gvol. 31 _gno. 4 _gp. 441-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.nucmedbio.2003.11.004 _zAvailable from publisher's website |
999 |
_c14806605 _d14806605 |